Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial

Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The NIH banner announcing terminology changes from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs was removed.
    Difference
    1%
    Check dated 2026-11-08T14:00:07.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study record remains unavailable and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:13:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice was added at the top of the page announcing an NIH website transition and linking to updates and FAQs. It appears above the existing unavailable-study error.
    Difference
    1%
    Check dated 2026-10-25T16:00:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:01:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision number in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:01:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and related content with an access-denied message.
    Difference
    18%
    Check dated 2026-09-20T20:25:34.000Z thumbnail image

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.